Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a non-pharmaceutical multimodal intervention program in a group setting for patients with mild cognitive impairment: A single-arm interventional study with pre-post and external control analyses.
Nakagawa S, Kowa H, Takagi Y, Kakei Y, Kagimura T, Sanada S, Nagai Y. Nakagawa S, et al. Among authors: sanada s. Contemp Clin Trials Commun. 2024 Jun 14;40:101326. doi: 10.1016/j.conctc.2024.101326. eCollection 2024 Aug. Contemp Clin Trials Commun. 2024. PMID: 39021673 Free PMC article.
Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan.
Aoki R, Nihei Y, Matsuzaki K, Suzuki H, Kihara M, Ogawa A, Nishino T, Sanada S, Yokote S, Okabe M, Shirai S, Fukuda A, Hoshino J, Kondo D, Yokoo T, Kashihara N, Narita I, Suzuki Y. Aoki R, et al. Among authors: sanada s. Kidney360. 2024 Sep 1;5(9):1322-1332. doi: 10.34067/KID.0000000000000498. Epub 2024 Jul 8. Kidney360. 2024. PMID: 38976886 Free PMC article.
Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.
Matsukuma K, Nishio S, Tasaki S, Park J, Nasu H, Yoshimitsu T, Tasaki K, Katsuda T, Terada A, Tsuda N, Sanada S, Ushijima K. Matsukuma K, et al. Among authors: sanada s. Kurume Med J. 2024 Jul 2;70(1.2):29-37. doi: 10.2739/kurumemedj.MS7012004. Epub 2024 Mar 29. Kurume Med J. 2024. PMID: 38556270 Free article.
The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study.
Mhawech-Fauceglia P, McCarthy D, Tonooka A, Scambia G, Garcia Y, Dundr P, Mills AM, Moore K, Sanada S, Bradford L, Stella GC, Bookman M, Sharma SK, Selle F, Molinero L, He Y, Khor V, Landen C, Lin YG. Mhawech-Fauceglia P, et al. Among authors: sanada s. Gynecol Oncol. 2024 Jul;186:17-25. doi: 10.1016/j.ygyno.2024.03.022. Epub 2024 Mar 29. Gynecol Oncol. 2024. PMID: 38554625 Free article. Clinical Trial.
Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.
Akiba J, Nakayama M, Kondo R, Kusano H, Ogasawara S, Mihara Y, Tanigawa M, Tsutsui K, Yano Y, Miyazaki D, Tokisawa S, Mitsuhashi T, Nomura H, Sanada S, Sakai H, Hisaka T, Yano H. Akiba J, et al. Among authors: sanada s. In Vivo. 2024 Mar-Apr;38(2):640-646. doi: 10.21873/invivo.13483. In Vivo. 2024. PMID: 38418151 Free PMC article.
385 results